Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib. [electronic resource]
Producer: 20130617Description: 32-5 p. digitalISSN:- 1872-7980
- Adult
- Antineoplastic Agents -- therapeutic use
- Benzamides -- therapeutic use
- Body Mass Index
- Chromosome Aberrations
- Cytogenetic Analysis
- DNA Mismatch Repair
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Piperazines -- therapeutic use
- Pyrimidines -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.